Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 1.995
+0.030 (1.53%)
Oct 7, 2026, 4:10 PM AEST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 2.59 billion as of October 7, 2026. Its market cap has decreased by -21.85% in one year.
Market Cap
2.59B
Enterprise Value
2.63B
Revenue
173.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
ChartMarket Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 2.59B, an increase of 3,283.40%. That is a compound annual growth rate of 17.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 2.59B | -25.76% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.24B |
| PYC Therapeutics | 2.64B |
| Neuren Pharmaceuticals | 2.56B |
| Clarity Pharmaceuticals | 753.62M |
| Clinuvel Pharmaceuticals | 409.98M |
| Starpharma Holdings | 388.63M |
| Racura Oncology | 363.71M |
| Tetratherix | 357.61M |